Skip to main content
logo
Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,255.40
+11.00 (0.88%)
At close: Aug 21, 2026, 4:00 PM EDT
1,257.01
+1.61 (0.13%)
Pre-market: Aug 24, 2026, 4:09 AM EDT

Eli Lilly Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
22,97419,79919,29217,60115,55812,72913,53311,43911,3038,7689,3539,4998,3126,9607,3026,9426,4887,8108,0006,773
Revenue Growth (YoY)
47.67%55.54%42.55%53.86%37.65%45.18%44.69%20.43%35.98%25.98%28.10%36.84%28.12%-10.88%-8.73%2.49%-3.74%14.76%7.53%17.98%
Cost of Revenue
3,2683,5773,3723,0082,4482,2252,4042,1712,1701,6741,7881,8601,8071,6271,5481,5791,4312,0722,1461,431
Gross Profit
19,70616,22215,92014,59313,11010,50411,1309,2689,1337,0957,5657,6396,5055,3335,7545,3635,0585,7385,8545,342
Selling, General & Admin
3,4302,9343,4582,6272,7532,4682,7711,9842,0031,8361,8101,6881,8101,6331,5501,5221,5311,4651,5191,505
Research & Development
3,8193,5103,8023,4663,3362,7343,0232,7342,7112,5232,5632,4092,3571,9851,9961,8031,7821,6101,8981,705
Operating Expenses
7,2496,4447,2596,0926,0895,2025,7944,7194,7144,3594,3724,0984,1663,6193,5463,3253,3133,0753,4183,211
Operating Income
12,4579,7788,6618,5007,0215,3025,3364,5504,4192,7363,1933,5412,3381,7152,2082,0381,7452,6632,4372,131
Interest Expense
-345-332-153.3-179.6-249-244-130.9-192.7-183.6-179.6-138.2-124.6-120.3-102.8-84-81.5-81.2-84.9-81.4-83.6
Interest & Investment Income
--672.465--555.947.837.345.844.548.94634.225.520.110.277.47
Currency Exchange Gain (Loss)
5397-468.4-170.3651-1333.80.2--2.4151.4-201--89.4-129.6-151.1--94-50.8
Other Non Operating Income (Expenses)
561170181.2-9.1-49218-252.9-21.1-7.831.2-173200.9-13.22.2-120.7110.9127.559.3111.370.9
EBT Excluding Unusual Items
12,7269,7138,8938,2066,9315,0635,5424,3844,2642,6313,0783,4652,2511,6482,1181,9581,6502,6452,3802,075
Merger & Restructuring Charges
---------------23---90.5-
Gain (Loss) on Sale of Investments
---14.146.9--29.5112.4-157.916121.3-62.9-64.9-13.7256.9-123.3-118.9-425.4-93.2-246.8
Asset Writedown
--------------206.5-206.5--108.1-
Legal Settlements
---------435-----------
Other Unusual Items
-703-279-84.1-364.9--35-344.4-81.6---67.7----221.6----207.7-405.2
Pretax Income
9,2478,8508,2667,2326,7773,4565,0381,5883,5172,5362,509427.22,0891,5302,0961,5661,0912,0541,8401,245
Income Tax Expense
2,1521,4541,6291,6501,116697628.5618.1550.2293.2319.1484.6325.7184.8158.7113.8138.4150.7113.8135.2
Earnings From Continuing Operations
7,0957,3966,6385,5835,6612,7594,410970.32,9672,2432,190-57.41,7631,3451,9381,452952.51,9031,7261,110
Net Income
7,0957,3966,6385,5835,6612,7594,410970.32,9672,2432,190-57.41,7631,3451,9381,452952.51,9031,7261,110
Net Income to Common
7,0957,3966,6385,5835,6612,7594,410970.32,9672,2432,190-57.41,7631,3451,9381,452952.51,9031,7261,110
Net Income Growth (YoY)
25.33%168.07%50.52%475.34%90.80%23.01%101.39%-68.27%66.77%13.00%-85.11%-29.32%12.26%30.77%-31.49%40.40%-18.46%-8.13%
Shares Outstanding (Basic)
892895898897898899903901901901904900900901905901900904910907
Shares Outstanding (Diluted)
894896898899900901903905904904904900903903905904903906910911
Shares Change (YoY)
-0.68%-0.52%-0.57%-0.69%-0.49%-0.35%-0.09%0.58%0.17%0.06%-0.08%-0.44%-0.02%-0.34%-0.53%-0.77%-0.82%-0.66%-0.33%-0.07%
EPS (Basic)
7.958.277.396.226.303.074.881.083.292.492.42-0.061.961.492.141.611.062.111.901.22
EPS (Diluted)
7.948.267.396.216.293.064.881.073.282.482.42-0.061.951.492.141.611.052.101.891.22
EPS Growth (YoY)
26.23%169.94%51.39%480.37%91.77%23.39%101.86%-68.20%66.44%13.01%-85.71%-29.05%12.99%31.97%-31.37%40.94%-18.33%-8.27%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
7,7573,007677.96,7481,390156977.72,361241.4179.7-1,3831,219-106.31,0621,1621,600812.32,1581,8651,295
Free Cash Flow Per Share
8.683.360.767.511.540.171.082.610.270.20-1.531.35-0.121.181.281.770.902.382.051.42
Dividend Per Share
1.7301.7301.5001.5001.5001.5001.3001.3001.3001.3001.1301.1301.1301.1300.9800.9800.9800.9800.8500.850
Dividend Growth (YoY)
15.33%15.33%15.38%15.38%15.38%15.38%15.04%15.04%15.04%15.04%15.31%15.31%15.31%15.31%15.29%15.29%15.29%15.29%14.87%14.87%
Gross Margin
85.78%81.93%82.52%82.91%84.27%82.52%82.24%81.02%80.80%80.91%80.88%80.42%78.26%76.63%78.80%77.25%77.95%73.47%73.18%78.87%
Operating Margin
54.22%49.39%44.90%48.29%45.13%41.65%39.43%39.77%39.09%31.20%34.14%37.28%28.13%24.64%30.23%29.36%26.89%34.10%30.46%31.47%
Profit Margin
30.88%37.35%34.41%31.72%36.39%21.68%32.58%8.48%26.25%25.58%23.41%-0.60%21.21%19.32%26.54%20.91%14.68%24.37%21.58%16.39%
Free Cash Flow Margin
33.76%15.19%3.51%38.34%8.93%1.23%7.22%20.64%2.14%2.05%-14.78%12.84%-1.28%15.26%15.91%23.04%12.52%27.63%23.31%19.11%
EBITDA
12,99110,2879,2478,9707,4995,7655,8215,0174,8333,1363,5813,9522,7052,0772,5832,4012,0943,0992,8822,514
EBITDA Margin
56.55%51.96%47.93%50.96%48.20%45.29%43.02%43.85%42.76%35.77%38.28%41.61%32.54%29.84%35.37%34.58%32.27%39.68%36.03%37.11%
D&A For EBITDA
534509585.7470478463485.2466.8414.4400.6387.7411366.3362.3375362.9348.9435.7445.7382.3
EBIT
12,4579,7788,6618,5007,0215,3025,3364,5504,4192,7363,1933,5412,3381,7152,2082,0381,7452,6632,4372,131
EBIT Margin
54.22%49.39%44.90%48.29%45.13%41.65%39.43%39.77%39.09%31.20%34.14%37.28%28.13%24.64%30.23%29.36%26.89%34.10%30.46%31.47%
Effective Tax Rate
23.27%16.43%19.70%22.81%16.47%20.17%12.47%38.91%15.64%11.56%12.72%113.44%15.59%12.08%7.57%7.27%12.69%7.34%6.19%10.86%
SEC Filings: 10-K · 10-Q